Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $268.07M.
ENTERPRISE VALUE (EV)
$268.07M
P3 Health Partners Inc.
Market Cap
$19.67M
Enterprise Value (EV)
$268.07M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| P3 Health Partners Inc. (PIII) | $19.67M | $268.07M |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.53M | $19.39M |
| Actuate Therapeutics Inc (ACTU)vs › | $19.43M | $15.41M |
| NextCure, Inc. (NXTC)vs › | $18.95M | $7.97M |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.89M | $18.21M |
| Cosmos Health Inc. (COSM)vs › | $17.83M | $32.00M |
| PAVmed Inc. (PAVM)vs › | $17.65M | $30.93M |
| Modular Medical, Inc. (MODD)vs › | $21.76M | $18.12M |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.11M | $13.91M |
Market Cap
$19.67M
Total Debt
$273.41M
Cash
$25.01M
Enterprise Value
$268.07M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
